Skip to Content
Cancer Care Inspired Stories

Genetic Testing Revealed a Hidden Risk, Action Changed the Outcome

Last updated: November 19, 2026

Anne Sowers recalls with bracing clarity the moment she received her genetic testing results.

“I remember standing in my bedroom,” she says. “I was looking at myself in the mirror and talking to [my genetic counselor] on the phone. I immediately felt like there was a floodlight that was turned on over my head.”

That fateful night in January 2023, Anne received the news that her test results revealed a rare genetic mutation called CDH1. The mutation impacts not just her but many members of her family as well. 

Anne calls the information she received terrible knowledge. But for her and her family, it’s deeper than that. It’s also empowering, galvanizing knowledge.

What would unfold over the next couple of years for Anne and her family would be at once devastating, enlightening and altogether life-altering.

“It may be terrible knowledge,” Anne says. “But it gives you an opportunity to make a choice, whereas otherwise you may not have a choice.”

A Diagnosis, A Catalyst

Anne decided to pursue genetic testing after her breast cancer diagnosis in 2023. Just 42 years old at the time and a mom of two young boys, the news was sobering.

For Anne, an Appleton resident, the time surrounding her diagnosis was extra challenging. She and her family had recently moved to Wisconsin from California and were still adjusting to life far away from loved ones and friends.

Not long after the move, Anne also received news that her mom had been diagnosed with glioblastoma, a form of brain cancer. All the while, she was also still mourning the loss of her dad, who 15 years prior had died of cancer under uncertain circumstances.

It was against that backdrop and amid traveling back and forth to California to be with her mom that Anne received her own diagnosis. Anne’s breast cancer was lobular, the rarer of the two main types. Lobular breast cancer is harder to detect and makes up just 10% to 15% of breast cancers. Ductal breast cancer accounts for 80% to 85% of all cases.

“The timing of that, I’ll never understand,” Anne, says. “I didn’t want my mom to have to worry about me while she was going through her own battle.”

In the aftermath of her diagnosis, Anne also chose to have genetic testing, a decision that would change everything.

Grappling with the Choice

When Anne, now 46, received her breast cancer diagnosis, her surgeon, Katherine DeAngeli, MD, encouraged her to have genetic testing. At first, Anne wasn’t sure. Yes, both of her parents had had cancer. But her mom had smoked for 50 years. And Anne attributed her dad’s cancer, in part, to his sedentary lifestyle.

Beyond thinking the test wouldn’t uncover anything, Anne worried about the cost and the implications for the ability to get insurance if the test did reveal anything. After all, she had a young family to worry about.

It was Emma Herlache, MS, CGC, a genetic counselor with ThedaCare, who helped persuade Anne.

“Genetic testing is a tool that we use to try to determine an individual person’s chance of getting cancer, trying to figure out if they’re at a higher risk than the average person with the goal being trying to change something because of that,” Herlache says.

“She’s so good at her job,” Anne says of Herlache. “She listens. She explains the nuances. Basically, she was like, ‘Let’s just see what it says.’”

Absorbing the Results

Anne could not have prepared herself for what the test revealed.

“Emma called me on a Friday night and said, ‘I am shocked by your results. It’s not what I thought. It’s way worse,’” Anne recounts.

The test had revealed the CDH1 mutation. The rare mutation is tied to a dramatically increased risk of developing lobular breast cancer and a type of stomach cancer called hereditary diffuse gastric cancer (HDGC).

Anne recalls the moment.

“I was in my fugue state of fear and anxiety. I didn’t know my [breast cancer] stage. I hadn’t had my surgery. I was watching my children walking around, not knowing if I was going to live to see them go to elementary school,” Anne says of her boys, who were 2 and 4 at the time.

The time following the news brought unthinkable trials for Anne and her family. Anne would undergo surgery for her breast cancer, followed by chemo and radiation.

In August 2023, Anne lost her mom. As she and her family grieved, they also began to come to grips with the implications of the test results. 

One Test: Many Impacts

To understand the implications of Anne’s test results, you have to begin with her dad. The circumstances surrounding Anne’s father’s death had left the family in torment.

Doctors thought Anne’s dad had appendix cancer that had progressed to colon cancer and claimed his life. Before his death, his family believed his cancer treatment had been going well. Just six weeks before his death, he’d had a clear PET scan.

After the test, he took a turn for the worse. He became unable to eat. His doctors recommended he have exploratory surgery. However, they couldn’t perform the procedure because they discovered his abdomen was so impacted by cancer. Two days later, he died.

“We’d had a lot of anger and fear and misery about our dad dying under very weird circumstances,” Anne says. “We didn’t understand how he had died or why.”

After Anne received her test results, it didn’t take long for the family to piece together that Anne’s dad had likely died of HDGC.

“I feel like Emma’s phone call and the genetic testing gave us all a modicum of peace,” Anne says.

Of course, the news also brought many other emotions as well. Anne has three younger siblings and two older half-siblings. Presuming that Anne’s dad had the CDH1 mutation, they each had a 50% chance of also having it. Each would handle the news in their own way.

For Anne, it was a time of reckoning with grief and uncertainty.

“The rest of 2024 was coming to grips with the new reality and what it means to survive cancer,” Anne says, unaware at that time of what lay ahead.

Big Decisions and Consequences

The next two years would bring unthinkable challenges for Anne’s family. In 2024 Anne’s sister and brother underwent genetic testing and discovered they had the CDH1 mutation. A second brother plans to have the test but hasn’t yet. Anne’s half-sister tested negative for the mutation, while her half-brother, Mark, declined to get tested.

For Anne and her siblings, the implications were significant. In families with a history of stomach cancer and/or lobular breast cancer, combined with the CDH1 mutation, males have an estimated 70% lifetime risk of developing HDGC. Females have an estimated 56% risk.

“For me as the oldest sibling in my family of origin, it was really stressful and hard,” Anne says.

Because of the way the disease grows and spreads, HDGC is hard to detect. It also often doesn’t cause symptoms until it’s in advanced stages. If caught after stage II, this type of stomach cancer typically has a poor prognosis.

Herlache says this is one way in which genetic testing or counseling can help empower people.

“For a lot of people who have a family history of cancer, the concern about cancer is there. It’s sort of this cloud that that covers them,” she says. “If we can find a genetic risk factor that really narrows that down and allows that person to take action based on that risk, that really can provide them with a lot of control, because they now have some action they can take.”

Watching and Waiting

Anne, along with her sister and brother with the mutation, began surveilling for HDGC. That involves tests and biopsies every six months.

It didn’t take long for one of Anne’s brother’s biopsies to produce a positive hit for HDGC. The news came as he and his wife were about to have their first child. Ultimately, he chose to have his stomach removed — a procedure called total gastrectomy — when his daughter was just 2 months old.

Anne’s sister, meanwhile, was preparing to have a preventive double mastectomy due to her risk for lobular breast cancer. In the process, it was discovered she had thyroid cancer. In undergoing treatment for that, she delayed the mastectomy.

Not long after Anne’s brother received his news, Anne’s sister also got a concerning HDGC biopsy result. That led her to choose to have a total gastrectomy in November 2025.

As the family grappled with the mounting setbacks, even worse news arrived in December 2025. Anne’s half-brother, Mark, fell gravely ill and was diagnosed with stage IV stomach cancer.

Mark’s illness progressed quickly. Despite attempting treatment, he died in April 2026.

Anne’s Turn

While Anne processed the news of her siblings and mourned Mark, she had her own big decision to make. She knew that studies show the longer HDGC surveillance continues, the more likely it will find a concern. Or worse, it could miss a problem altogether.

Anne had long planned for a total gastrectomy, but the decision of when to have it was not straightforward for her. Because she was taking a course of targeted oral therapy for her breast cancer, she was concerned about how her body would absorb the medication if she didn’t have a stomach.

In consulting with her medical team, they thought it would be safe for Anne to put off having the gastrectomy until summer 2026. The wait felt interminable.

“For me, even the two and half years I was surveilling were incredibly stressful. No one knows how fast or slow [HDGC] develops,” Anne says of feeling like a “ticking time bomb.”

Anne’s surgery was scheduled for June 2026. Shortly before the day arrived, Anne’s sister received more bad news. She was diagnosed with lobular breast cancer — her third cancer diagnosis in just 14 months.

In the face of unthinkable suffering and a dizzying number of setbacks, Anne had her surgery in June. As she suspected, it couldn’t have come soon enough. Pathology following the procedure showed she had two types of stomach cancer.

“My decision was correct, but it wasn’t easy. No one wants to remove their stomach. It’s a life changer. You have to really care for yourself after this,” she says, reflecting it on it all.

Anne describes the experience of living without a stomach as “weirdly OK.” She’s adapted her eating habits to take small, slow bites. She also focuses on protein intake while limiting carbohydrates.

“For me, it’s far preferable to the alternative,” she says.

Advocacy and Awareness

It’s natural to wonder how someone could survive such adversity. For Anne, it’s a combination of counseling, yoga, meditation and mindfulness, along with the love and support of her husband, family and friends.

“I try to use all of my tools. It takes all of my tools,” she says.

In addition to that, advocacy has proven a powerful antidote. Anne works with nonprofit organization Debbie’s Dream Foundation to advocate and raise awareness around stomach cancer. For her, it’s healing and purposeful to share her story.

“It’s the real stories that are there, and your voice is shaking, and you’re showing your little photos of your family that has been decimated by this, and you’re asking [lawmakers] for their support for certain bills or initiatives,” she says. “I show them my little boys and I say, ‘I don’t want them to have to get their stomachs removed if they have this mutation.’”

‘Another Life Saved’

With much still unknown about CDH1, Anne coexists with uncertainty. One thing she knows: the lives of her and her family were changed through the genetic testing she received through ThedaCare. She and Herlache remain connected.

“Every time one of my siblings or I receive another diagnosis, I reach out to her and say thank you: another life saved,” Anne says.

Herlache says the experience has been equally profound for her. “Having been able to walk through this journey with Anne has been special for me as a healthcare provider. Being able to see the impact of what we do here at ThedaCare is really meaningful.”

When Anne thinks of the impact, it of course extends to her two boys, now nearly 6 and 8. She hopes so much: first and foremost, that they will be spared what she has endured.

“If they do have the mutation, I know that I will set the example that you can remove your stomach and have a healthy, full, exuberant life,” she says.

In the face of the awful and the wonderful and the unknown, Anne stands resolute.

“We can’t know what the future will bring. We don’t know what this mutation might be doing to any of us at this time. But what we know now is that we have this day and we’ve done everything we can. Go and live your life to the fullest and love your people.”

Learn more about genetic counseling and cancer risk assessment through ThedaCare Cancer Care.

Tags: Cancer Risk Assessment Cancer Survivor Story CDH1 Mutation Family Cancer Risk Genetic Counseling HDGC Hereditary Diffuse Gastric Cancer Lobular Breast Cancer Prevent Cancer Care Prophylactic Total Gastrectomy Stomach Cancer Awareness ThedaCare Cancer Care ThedaCare Genetic Testing

Related Articles

Close-up of woman breaking down cigarette to pieces. Quit smoking concept Link to the full post Cancer Care Healthcare 101

Five Facts That May Inspire You to Quit Smoking

Home, hands and old man with chest pain, cough and cardiac symptoms in lounge. Closeup, hypertension or elderly person with heart attack signs, retirement and viral infection with illness or asthma Link to the full post Cancer Care Healthcare 101

5 Lung Cancer Myths That Could Put Your Health at Risk

Back to site